Evidence map›Paper›PMID 37973170›Full record

SynthesisBMJ (Clinical research ed.)2023

Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis.

Safi U Khan, Siddharth Agarwal, Hassaan B Arshad, Usman Ali Akbar, Mamas A Mamas, Shilpkumar Arora, Usman Baber, Sachin S Goel, Neal S Kleiman, Alpesh R Shah

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Article
  6. Intravascular Imaging for Facilitated Coronary Interventions in DES Era.Journal of cardiovascular development and disease · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Factors Contributing to Low Utilization of Intracoronary Imaging in Clinical Practice: A White Paper.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Safi U KhanDepartment of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.ORCID 0000-0003-1559-6911
Siddharth AgarwalDepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Hassaan B ArshadDepartment of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.
Usman Ali AkbarDepartment of Medicine, West Virginia University - Camden Clark Medical Center, Parkersburg, WV, USA.
Mamas A MamasKeele Cardiovascular Research Group, Keele University, Stroke-On-Trent, UK.
Shilpkumar AroraUniversity Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH, USA.
Usman BaberDepartment of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Sachin S GoelDepartment of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.
Neal S KleimanDepartment of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.
Alpesh R ShahDepartment of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.
Houston Methodist · USUniversity of Oklahoma Health Sciences Center · USThomas Jefferson University · USUniversity Hospitals of Cleveland · USWest Virginia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the absolute treatment effects of intravascular imaging guided versus angiography guided percutaneous coronary intervention in patients with coronary artery disease, considering their baseline risk.

designSystematic review and meta-analysis. DATA SOURCES: PubMed/Medline, Embase, and Cochrane Library databases up to 31 August 2023. STUDY SELECTION: Randomized controlled trials comparing intravascular imaging (intravascular ultrasonography or optical coherence tomography) guided versus coronary angiography guided percutaneous coronary intervention in adults with coronary artery disease.

main outcome measuresRandom effect meta-analysis and GRADE (grading of recommendations, assessment, development, and evaluation) were used to assess certainty of evidence. Data included rate ratios and absolute risks per 1000 people for cardiac death, myocardial infarction, stent thrombosis, target vessel revascularization, and target lesion revascularization. Absolute risk differences were estimated using SYNTAX risk categories for baseline risks at five years, assuming constant rate ratios across different cardiovascular risk thresholds.

resultsIn 20 randomized controlled trials (n=11 698), intravascular imaging guided percutaneous coronary intervention was associated with a reduced risk of cardiac death (rate ratio 0.53, 95% confidence interval 0.39 to 0.72), myocardial infarction (0.81, 0.68 to 0.97), stent thrombosis (0.44, 0.27 to 0.72), target vessel revascularization (0.74, 0.61 to 0.89), and target lesion revascularization (0.71, 0.59 to 0.86) but not all cause death (0.81, 0.64 to 1.02). Using SYNTAX risk categories, high certainty evidence showed that from low risk to high risk, intravascular imaging was likely associated with 23 to 64 fewer cardiac deaths, 15 to 19 fewer myocardial infarctions, 9 to 13 fewer stent thrombosis events, 28 to 38 fewer target vessel revascularization events, and 35 to 48 fewer target lesion revascularization events per 1000 people.

conclusionsCompared with coronary angiography guided percutaneous coronary intervention, intravascular imaging guided percutaneous coronary intervention was associated with significantly reduced cardiac death and cardiovascular outcomes in patients with coronary artery disease. The estimated absolute effects of intravascular imaging guided percutaneous coronary intervention showed a proportional relation with baseline risk, driven by the severity and complexity of coronary artery disease. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42023433568.

Indexed as

Coronary Artery DiseaseDrug-Eluting StentsMyocardial InfarctionPercutaneous Coronary InterventionThrombosisCoronary AngiographyDeathHumansRisk FactorsTreatment Outcome

Identifiers

PMID37973170
PMCPMC10652093
OpenAlexW4388734486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.